Functional Validation of the Putative Oncogenic Activity of

CRISPR-dCas9 Epigenetic Editing PLAU oncogene triple negative breast cancer

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
30 Dec 2022
Historique:
received: 24 11 2022
revised: 21 12 2022
accepted: 27 12 2022
entrez: 21 1 2023
pubmed: 22 1 2023
medline: 22 1 2023
Statut: epublish

Résumé

Plasminogen activator, urokinase (

Identifiants

pubmed: 36672610
pii: biomedicines11010102
doi: 10.3390/biomedicines11010102
pmc: PMC9856075
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : European Union H2020-MSCA-ITN-2014-ETN EpiPredict
ID : 642691
Organisme : Foundation Against Cancer (Belgium)
ID : 7872
Organisme : Research Foundation Flanders (Belgium)
ID : FWO G1179120N, G059713N

Références

J Neurosci. 2017 Oct 25;37(43):10310-10322
pubmed: 28931568
Nucleic Acids Res. 2014;42(17):11011-24
pubmed: 25200076
J Org Chem. 1969 Dec;34(12):3858-66
pubmed: 5357526
Nat Nanotechnol. 2020 Apr;15(4):313-320
pubmed: 32251383
Biochim Biophys Acta. 2009 Nov;1794(11):1654-62
pubmed: 19654054
Clin Cancer Res. 2004 May 1;10(9):3035-41
pubmed: 15131040
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Curr Pharm Des. 2011;17(19):1970-8
pubmed: 21711234
Gene Ther. 2017 Mar;24(3):144-150
pubmed: 27797355
Exp Cell Res. 2018 Jul 1;368(1):67-74
pubmed: 29689276
Reprod Fertil Dev. 2017 Oct;29(11):2149-2156
pubmed: 28298247
Molecules. 2019 Nov 20;24(23):
pubmed: 31756973
Mol Ther Methods Clin Dev. 2017 Dec 01;8:87-104
pubmed: 29326962
Cell Death Dis. 2014 Jan 30;5:e1043
pubmed: 24481457
Carcinogenesis. 2014 Jan;35(1):138-44
pubmed: 23985780
Invest Ophthalmol Vis Sci. 2015 May;56(5):3383-92
pubmed: 26024123
Eur J Cancer. 2013 May;49(8):1825-35
pubmed: 23490655
Methods Mol Biol. 2011;740:7-12
pubmed: 21468962
Nat Commun. 2016 Aug 10;7:12284
pubmed: 27506838
Breast Cancer Res. 2014 Aug 22;16(4):428
pubmed: 25677449
Sci Rep. 2019 Feb 19;9(1):2318
pubmed: 30783124
Nat Protoc. 2018 Dec;13(12):2991-3017
pubmed: 30455477
Nucleic Acids Res. 2018 May 18;46(9):4456-4468
pubmed: 29538770
Adv Exp Med Biol. 2015;867:145-56
pubmed: 26530365
Int J Mol Sci. 2017 May 19;18(5):
pubmed: 28534825
PLoS One. 2010 Oct 21;5(10):e13536
pubmed: 20975835
Cancer Res. 1991 Jan 1;51(1):274-81
pubmed: 1988089
J Neurol Exp Neurosci. 2018;4(2):24-29
pubmed: 30417161
Cancer Res. 2004 Jul 1;64(13):4563-8
pubmed: 15231667
Science. 2018 Jan 12;359(6372):
pubmed: 29326244
Oncogene. 2015 Oct;34(43):5427-35
pubmed: 25684141
ISRN Dermatol. 2013 Jul 18;2013:597927
pubmed: 23984088
Clin Chim Acta. 2019 Jan;488:116-121
pubmed: 30395864
Adv Exp Med Biol. 2022;1389:515-533
pubmed: 36350521
Nucleic Acids Res. 2012 Nov;40(21):10596-613
pubmed: 23002135
Cell Signal. 2012 Sep;24(9):1847-55
pubmed: 22617030
Cancer Lett. 2013 Jun 28;334(1):101-8
pubmed: 22935676
Proc Natl Acad Sci U S A. 2019 Sep 10;116(37):18295-18303
pubmed: 31451668
PLoS One. 2014 Feb 03;9(2):e87850
pubmed: 24498382
J Natl Cancer Inst. 1995 May 17;87(10):751-6
pubmed: 7563153
Methods Mol Biol. 2018;1767:395-415
pubmed: 29524148
PLoS One. 2014 May 23;9(5):e97639
pubmed: 24858547
Thromb Haemost. 2019 Dec;119(12):1968-1980
pubmed: 31705517
J Nanobiotechnology. 2020 Jan 31;18(1):26
pubmed: 32005170
J Biol Chem. 2002 Nov 1;277(44):41571-9
pubmed: 12198113
Mol Cancer Res. 2013 Sep;11(9):1029-39
pubmed: 23814024
Exp Mol Med. 2015 Jun 05;47:e166
pubmed: 26045254
Cell. 2021 Apr 29;184(9):2503-2519.e17
pubmed: 33838111
Genome Biol. 2014 Feb 03;15(2):R29
pubmed: 24485249
Cancer. 1988 Aug 1;62(3):531-3
pubmed: 3134120
Neurobiol Dis. 2012 Apr;46(1):215-24
pubmed: 22293605
Nat Biotechnol. 2022 Sep 5;:
pubmed: 36058989
Nucleic Acids Res. 2016 May 5;44(8):e71
pubmed: 26704973
J Natl Cancer Inst. 2002 Jan 16;94(2):116-28
pubmed: 11792750
J Natl Cancer Inst. 2001 Jun 20;93(12):913-20
pubmed: 11416112
Clin Chem. 1998 Jun;44(6 Pt 1):1177-83
pubmed: 9625040
Cancer Res. 2008 Sep 15;68(18):7661-9
pubmed: 18794155
Nat Cell Biol. 2021 Jan;23(1):11-22
pubmed: 33420494
Trends Genet. 2019 Jul;35(7):527-541
pubmed: 31128888
Clin Exp Metastasis. 1995 Jul;13(4):296-302
pubmed: 7606892
Thromb Haemost. 1994 Apr;71(4):474-80
pubmed: 8052966
BioDrugs. 2017 Aug;31(4):317-334
pubmed: 28669112
Nutr Cancer. 2008;60 Suppl 1:51-60
pubmed: 19003581
Biochem Pharmacol. 2012 Nov 15;84(10):1282-91
pubmed: 22981382
Biochem Pharmacol. 2020 Mar;173:113602
pubmed: 31404528
Oncotarget. 2017 Jun 20;8(25):40434-40453
pubmed: 28467815
J Clin Invest. 2018 Aug 1;128(8):3341-3355
pubmed: 29939160
Anticancer Res. 2018 Dec;38(12):6753-6758
pubmed: 30504386
Cell. 2017 Dec 14;171(7):1495-1507.e15
pubmed: 29224783
Food Chem Toxicol. 2019 Feb;124:219-230
pubmed: 30529123
Front Oncol. 2018 Feb 12;8:24
pubmed: 29484286
Biomark Insights. 2016 Aug 16;11:105-11
pubmed: 27578963
Biochem Biophys Res Commun. 2011 Nov 18;415(2):325-9
pubmed: 22033405
Am J Physiol Lung Cell Mol Physiol. 2017 Mar 1;312(3):L334-L347
pubmed: 28011616
Cell. 2016 Sep 22;167(1):219-232.e14
pubmed: 27662090
J Breast Cancer. 2013 Mar;16(1):23-31
pubmed: 23593078
Angiogenesis. 2004;7(2):115-22
pubmed: 15516832
Cell. 2020 Apr 2;181(1):136-150
pubmed: 32243786
Cell. 2015 Oct 8;163(2):506-19
pubmed: 26451490

Auteurs

Federica Sarno (F)

Epigenetic Editing, Department of Pathology and Medical Biology, University Medical Centre Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.

Désirée Goubert (D)

Epigenetic Editing, Department of Pathology and Medical Biology, University Medical Centre Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.

Emilie Logie (E)

Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), Laboratory of Protein Chemistry, Proteomics and Epigenetic Signalling (PPES), Department of Biomedical Sciences, University of Antwerp, 2610 Wilrijk, Belgium.

Martijn G S Rutten (MGS)

Epigenetic Editing, Department of Pathology and Medical Biology, University Medical Centre Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.
Department of Paediatrics, University Medical Centre Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.

Mihaly Koncz (M)

Swammerdam Institute for Life Sciences, University of Amsterdam, Science Park 904, 1098 XH Amsterdam, The Netherlands.
Institute of Biochemistry, Biological Research Centre, H-6726 Szeged, Hungary.
Doctoral School of Biology, Faculty of Science and Informatics, University of Szeged, H-6726 Szeged, Hungary.

Christophe Deben (C)

Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, 2610 Wilrijk, Belgium.

Anita E Niemarkt (AE)

Epigenetic Editing, Department of Pathology and Medical Biology, University Medical Centre Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.

Lucia Altucci (L)

Department of Precision Medicine, Universita' degli Studi della Campania "Luigi Vanvitelli", 80138 Naples, Italy.
Biogem Institute of Molecular and Genetic Biology, 83031 Ariano Irpino, Italy.
IEOS Istituto per l'Endocrinologia e l'Oncologia "Gaetano Salvatore", Via Pansini, 80131 Napoli, Italy.

Pernette J Verschure (PJ)

Swammerdam Institute for Life Sciences, University of Amsterdam, Science Park 904, 1098 XH Amsterdam, The Netherlands.

Antal Kiss (A)

Institute of Biochemistry, Biological Research Centre, H-6726 Szeged, Hungary.

Wim Vanden Berghe (WV)

Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), Laboratory of Protein Chemistry, Proteomics and Epigenetic Signalling (PPES), Department of Biomedical Sciences, University of Antwerp, 2610 Wilrijk, Belgium.

Marianne G Rots (MG)

Epigenetic Editing, Department of Pathology and Medical Biology, University Medical Centre Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.

Classifications MeSH